Company Overview and News

Oakmark Equity And Income Fund: Q1 2018

7h seekingalpha
Includes detailed analysis of Oakmark Equity And Income Fund's positions in APC, CSL, CMCSA, LBRDA, LBRDK, CLGX, QRVO, REGN.
Upvote Downvote

8 Casson Square: central riverside living on London's South Bank

11h scmp
Southbank Place is an exciting new residential, commercial and retail development in the heart of South Bank.
Upvote Downvote

JLL / Jones Lang LaSalle Inc. DEFA14A

Upvote Downvote

JLL / Jones Lang LaSalle Inc. null

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )
Upvote Downvote

Acanthe Développement : Communiqué sur les résultats annuels 2017

2018-04-19 globenewswire
ANR par action au 31/12/2017 1,120 € / action Après la distribution de 0,30 euros intervenue le 12 février 2018, l'ANR s'élève à 0,820 € par action
Upvote Downvote

A Bon-Ton liquidation jeopardizes US mall owners already in trouble

2018-04-17 cnbc
As Bon-Ton heads to liquidation, the shuttering of more than 200 regional department stores jeopardizes U.S. mall owners already struggling to fill empty stores.
Upvote Downvote

Teslas and Porsches Cost Less Than Golf Carts in Hong Kong - Bloomberg

2018-04-17 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

UPDATE 2-Pebblebrook boosts offer for U.S. hotels owner LaSalle

2018-04-16 reuters
(Reuters) - Pebblebrook Hotel Trust (PEB.N) has sweetened its $3 billion-plus offer to buy U.S. peer LaSalle Hotel Properties (LHO.N) after the owner of high-end locations including ‘W’ Los Angeles saw an initial bid rebuffed last month.
Upvote Downvote

Greenwich Peninsula: a new way to live in London

2018-04-16 scmp
Riverfront apartments are now available at London's largest single-owned development project from Hong Kong's Knight Dragon.
Upvote Downvote

JLL / Jones Lang LaSalle Inc. / VANGUARD GROUP INC - null (Passive Investment)

joneslanglasalleinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
Upvote Downvote

JLL / Jones Lang LaSalle Inc. / VANGUARD GROUP INC - null (Passive Investment)

joneslanglasalleinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
Upvote Downvote

One attraction still drawing shoppers to malls: Food

2018-04-10 cnbc
You might've noticed more and more mall food courts are changing, ditching fast-food chains for local eateries. And that's not on accident.
Upvote Downvote

Rahul Bhatia’s InterGlobe in race to buy WaveRock

2018-04-09 livemint
Mumbai: InterGlobe Enterprises Pvt. Ltd, which owns India’s largest airline IndiGo, has bid around Rs1,800 crore for Hyderabad’s WaveRock office complex, two people aware of the development said.
Upvote Downvote featured highlights include:, Align, Axon Enterprise, Antero and Jones Lang

2018-04-09 zacks
Chicago, IL – April 9, 2018 - Stocks in this week’s article Inc. (AMZN - Free Report) , Align Technology Inc. (ALGN - Free Report) , Axon Enterprise Inc. (AAXN - Free Report) , Antero Resources Corp. (AR - Free Report) and Jones Lang LaSalle Inc. (JLL - Free Report) .
Upvote Downvote

The Silk District: meticulous apartments in London's vibrant Whitechapel

2018-04-09 scmp
Whitechapel properties will be among the biggest beneficiaries of London's forthcoming Crossrail, offering better value and higher price growth than neighboring districts.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 48020Q107